Career Enhancement Program

职业提升计划

基本信息

  • 批准号:
    10704117
  • 负责人:
  • 金额:
    $ 6.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-13 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

CAREER ENHANCEMENT PROGRAM RESEARCH PLAN CEP Director: Simon Powell, MD PhD CEP Co-Director: Jorge Reis-Filho, MD PhD Abstract: The SPORE Career Enhancement Program (CEP) aims to prepare physicians and scientists for independent careers in translational research in breast cancer. Our goal is that investigators supported through this process will spend their professional lifetimes conducting translational research in breast cancer and become academic leaders in the field. Memorial Sloan Kettering Cancer Center (MSKCC) is ideally suited for this task, because of the scientific and clinical environment at our Manhattan campus and affiliated institutions, and our long tradition of training physicians and scientists of the highest quality. Our institutional environment includes numerous NIH training grants, including a K12 grant for translational science training, a T32 grant to train PhDs in translational research in Oncology, a Certificate Program in Clinical Investigation integrated with the Clinical and Translational Science Program at Weill Cornell, and a well-established junior faculty mentoring program. We plan to use the SPORE Career Enhancement funds over the next 5 years to enhance the existing formal mentoring programs. We will encourage more physician trainees to focus on translational research in breast cancer, in particular to leverage the emerging knowledge of DNA repair defects and specific patterns of genetic instability in breast cancers to deliver targeted treatments to individual breast cancer patients. We will strive to attract basic, translational and population scientists who are interested in devoting their careers to making discoveries that have a realistic potential to clinical applications. The specific aims of the MSKCC Breast SPORE Career Enhancement Program are to support the mentoring and research of junior faculty for careers in translational research in breast cancer, using a dual clinical and laboratory/population science mentorship model, and to recruit and mentor new junior faculty members to work in breast cancer translational research.
职业发展研究中心 CEP主任:Simon Powell,MD PhD CEP联合主任:Jorge Reis-Filho,MD PhD 摘要: SPORE职业提升计划(CEP)旨在为独立的医生和科学家做好准备。 乳腺癌的转化研究。我们的目标是,调查人员通过这一进程的支持, 将在职业生涯中从事乳腺癌的转化研究, 领导者在外地。纪念斯隆凯特琳癌症中心(MSKCC)非常适合这项任务,因为 我们曼哈顿校区和附属机构的科学和临床环境,以及我们悠久的传统 培养最高质量的医生和科学家。我们的机构环境包括许多NIH 培训赠款,包括用于翻译科学培训的K12补助金,用于培养翻译科学博士的T32补助金 肿瘤学研究,临床研究与临床和转化相结合的证书课程 威尔康奈尔大学的科学课程,以及一个完善的初级教师指导计划。我们计划利用 未来5年,SPORE职业发展基金将用于加强现有的正式辅导计划。 我们将鼓励更多的实习医生专注于乳腺癌的转化研究,特别是 利用DNA修复缺陷和乳腺癌遗传不稳定性的特定模式的新知识, 为乳腺癌患者提供有针对性的治疗。我们将努力吸引基本的, 翻译和人口科学家谁有兴趣把自己的职业生涯,使发现, 具有临床应用的现实潜力。MSKCC Breast SPORE职业的具体目标 增强计划是为了支持初级教师的指导和研究, 乳腺癌研究,采用临床和实验室/人口科学双导师模式, 招募和指导新的初级教员从事乳腺癌转化研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Simon N. Powell其他文献

The predicted effect of HDR dose heterogeneity on local/regional control for post-surgical patients: Location matters
  • DOI:
    10.1016/j.brachy.2006.03.090
  • 发表时间:
    2006-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Joseph O. Deasy;Simon N. Powell;Imran Zoberi
  • 通讯作者:
    Imran Zoberi
A local ATR-dependent checkpoint pathway is activated by a site-specific replication fork block in human cells
人类细胞中的位点特异性复制叉阻断激活局部 ATR 依赖性检查点通路
  • DOI:
    10.1101/2023.03.26.534293
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sana Ahmed;Manisha Jalan;Helen E. Grimsley;Aman Sharma;Shyam Twayana;Settapong T. Kosiyatrakul;Christopher Thompson;C. Schildkraut;Simon N. Powell
  • 通讯作者:
    Simon N. Powell
Defining the Optimal Dose for 3-Dimensional Conformal Accelerated Partial Breast Irradiation: 15-Year Follow-Up of a Dose-Escalation Trial
定义三维适形加速部分乳腺照射的最佳剂量:一项剂量递增试验的 15 年随访
  • DOI:
    10.1016/j.ijrobp.2024.10.029
  • 发表时间:
    2025-03-15
  • 期刊:
  • 影响因子:
    6.500
  • 作者:
    Alphonse G. Taghian;George E. Naoum;Lior Z. Braunstein;Andrzej Niemierko;Barbara L. Smith;Michele A. Gadd;Simon N. Powell;Abram Recht
  • 通讯作者:
    Abram Recht
The biology of radioresistance: similarities, differences and interactions with drug resistance
  • DOI:
    10.1007/bf00744671
  • 发表时间:
    1993-01-01
  • 期刊:
  • 影响因子:
    1.700
  • 作者:
    Simon N. Powell;Edward H. Abraham
  • 通讯作者:
    Edward H. Abraham
Ultrasound-mediated mechanical forces selectively kill tumor cells
超声介导的机械力选择性杀死肿瘤细胞
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Tijore;F. Margadant;Mingxi Yao;Anushya Hariharan;C. Chew;Simon N. Powell;G. Bonney;M. Sheetz
  • 通讯作者:
    M. Sheetz

Simon N. Powell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Simon N. Powell', 18)}}的其他基金

MSK SPORE in Genomic Instability in Breast Cancer
MSK SPORE 在乳腺癌基因组不稳定性中的作用
  • 批准号:
    10237877
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10478022
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
MSK SPORE in Genomic Instability in Breast Cancer
MSK SPORE 在乳腺癌基因组不稳定性中的作用
  • 批准号:
    10704063
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10704069
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
  • 批准号:
    10478008
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10237878
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
  • 批准号:
    10237881
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
MSK SPORE in Genomic Instability in Breast Cancer
MSK SPORE 在乳腺癌基因组不稳定性中的作用
  • 批准号:
    10477981
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
  • 批准号:
    10704096
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10237885
  • 财政年份:
    2020
  • 资助金额:
    $ 6.71万
  • 项目类别:

相似海外基金

Research Project 2 Proteogenomic-guided therapeutic targeting of breast cancer patient-derived xenograft metastases
研究项目 2 蛋白质基因组引导的乳腺癌患者异种移植转移的治疗靶向
  • 批准号:
    10733315
  • 财政年份:
    2023
  • 资助金额:
    $ 6.71万
  • 项目类别:
SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival
SQLE 和甾醇导致 ER 乳腺癌患者生存率的种族差异
  • 批准号:
    10571020
  • 财政年份:
    2023
  • 资助金额:
    $ 6.71万
  • 项目类别:
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
华盛顿大学 PDX 开发和试验中心 - Abemaciclib 联合 Olaparib 在卵巢癌和乳腺癌患者异种移植模型中的评估
  • 批准号:
    10582164
  • 财政年份:
    2022
  • 资助金额:
    $ 6.71万
  • 项目类别:
Identification of Mammaglobin-A breast derived EVs in breast cancer patient plasma using nanoscale flow cytometry
使用纳米级流式细胞术鉴定乳腺癌患者血浆中的乳房珠蛋白-A 乳源性 EV
  • 批准号:
    411913
  • 财政年份:
    2019
  • 资助金额:
    $ 6.71万
  • 项目类别:
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
确定南卡罗来纳州乳腺癌患者治疗和死亡率种族差异的预测因素以及乳腺癌患者导航的地理空间调查
  • 批准号:
    9978735
  • 财政年份:
    2019
  • 资助金额:
    $ 6.71万
  • 项目类别:
Maximizing metastatic breast cancer patient outcomes using diet and exercise
通过饮食和运动最大限度地提高转移性​​乳腺癌患者的治疗效果
  • 批准号:
    388211
  • 财政年份:
    2018
  • 资助金额:
    $ 6.71万
  • 项目类别:
    Operating Grants
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
确定南卡罗来纳州乳腺癌患者治疗和死亡率种族差异的预测因素以及乳腺癌患者导航的地理空间调查
  • 批准号:
    9435745
  • 财政年份:
    2017
  • 资助金额:
    $ 6.71万
  • 项目类别:
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
确定南卡罗来纳州乳腺癌患者治疗和死亡率种族差异的预测因素以及乳腺癌患者导航的地理空间调查
  • 批准号:
    9567963
  • 财政年份:
    2017
  • 资助金额:
    $ 6.71万
  • 项目类别:
Development of long term support program for breast cancer patient after reconstruction
为乳腺癌患者重建后制定长期支持计划
  • 批准号:
    16K20779
  • 财政年份:
    2016
  • 资助金额:
    $ 6.71万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of a Smartphone-integrated Cancer Biomarker Sensor for Breast Cancer Patient Management
开发用于乳腺癌患者管理的智能手机集成癌症生物标志物传感器
  • 批准号:
    478406-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 6.71万
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了